180 related articles for article (PubMed ID: 12784550)
1. [Diagnostic markers in the prevention of bovine herpesvirus type 1: possibilities and limitations].
Beer M; König P; Schielke G; Trapp S
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):183-91. PubMed ID: 12784550
[TBL] [Abstract][Full Text] [Related]
2. [Eradication of BHV-1 in cattle herds in Saxony-Anhalts using a vaccine lacking a marker--report of an experience].
Gehrmann B; Tyrpe A; Körber R
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):203-7. PubMed ID: 12784553
[TBL] [Abstract][Full Text] [Related]
3. [Conventional and marked BHV-1 vaccines in Germany: a brief review].
Trapp S; König P; Beer M
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):208-15. PubMed ID: 12784554
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a triplex real-time PCR assay for the rapid detection and differentiation of wild-type and glycoprotein E-deleted vaccine strains of Bovine herpesvirus type 1.
Wernike K; Hoffmann B; Kalthoff D; König P; Beer M
J Virol Methods; 2011 Jun; 174(1-2):77-84. PubMed ID: 21458493
[TBL] [Abstract][Full Text] [Related]
6. [BHV-1 eradication program in Bavaria: a marker-independent strategy].
Truyen U; Isa G; Gerbermann H; Bogner KH; Banzhaf K; Köstler M; Pauels FJ; Czerny CP; Wittkowski G
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):197-202. PubMed ID: 12784552
[TBL] [Abstract][Full Text] [Related]
7. [Requirements for the use of ELISA systems in eradication programs].
Bogner KH
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):259-62. PubMed ID: 12784562
[TBL] [Abstract][Full Text] [Related]
8. [Comparative studies with three different bovine blood sample BHV-1 ELISA tests: indirect ELISA and bG-blocking-ELISA].
Isa G; Schelp C; Truyen U
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):192-6. PubMed ID: 12784551
[TBL] [Abstract][Full Text] [Related]
9. Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype.
Muylkens B; Meurens F; Schynts F; de Fays K; Pourchet A; Thiry J; Vanderplasschen A; Antoine N; Thiry E
Vet Microbiol; 2006 Mar; 113(3-4):283-91. PubMed ID: 16321480
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of a glycoprotein E gene-deleted bovine herpesvirus type 1 recombinant.
Chowdhury SI; Ross CS; Lee BJ; Hall V; Chu HJ
Am J Vet Res; 1999 Feb; 60(2):227-32. PubMed ID: 10048557
[TBL] [Abstract][Full Text] [Related]
11. Baculovirus expression and diagnostic utility of the glycoprotein E of bovine herpesvirus-1.1 Egyptian strain "Abu-Hammad".
El-Kholy AA; Abdou ER; Rady DI; Elseafy MM
J Virol Methods; 2013 Jul; 191(1):33-40. PubMed ID: 23557665
[TBL] [Abstract][Full Text] [Related]
12. Detection of bovine herpesvirus-1 infection in breeding bull semen by virus isolation and polymerase chain reaction.
Deka D; Ramneek ; Maiti NK; Oberoi MS
Rev Sci Tech; 2005 Dec; 24(3):1085-94. PubMed ID: 16642777
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of serum antibodies to bovine herpesvirus-1 and bovine viral diarrhea virus in beef cattle in Uruguay.
Guarino H; Núñez A; Repiso MV; Gil A; Dargatz DA
Prev Vet Med; 2008 Jun; 85(1-2):34-40. PubMed ID: 18280598
[TBL] [Abstract][Full Text] [Related]
14. Rationale and perspectives on the success of vaccination against bovine herpesvirus-1.
van Drunen Littel-van den Hurk S
Vet Microbiol; 2006 Mar; 113(3-4):275-82. PubMed ID: 16330163
[TBL] [Abstract][Full Text] [Related]
15. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer.
Kalthoff D; König P; Trapp S; Beer M
Vaccine; 2010 Aug; 28(36):5871-7. PubMed ID: 20600486
[TBL] [Abstract][Full Text] [Related]
16. Isolation of a glycoprotein E-deleted bovine herpesvirus type 1 strain in the field.
Dispas M; Schynts F; Lemaire M; Letellier C; Vanopdenbosch E; Thiry E; Kerkhofs P
Vet Rec; 2003 Aug; 153(7):209-12. PubMed ID: 12956298
[TBL] [Abstract][Full Text] [Related]
17. Establishment of latency associated with glycoprotein E (gE) seroconversion after bovine herpesvirus 1 infection in calves with high levels of passive antibodies lacking gE antibodies.
Schynts F; Lemaire M; Ros C; Belak S; Thiry E
Vet Microbiol; 2001 Sep; 82(3):211-22. PubMed ID: 11470543
[TBL] [Abstract][Full Text] [Related]
18. The use of marker vaccines in eradication of herpesviruses.
van Oirschot JT; Kaashoek MJ; Rijsewijk FA; Stegeman JA
J Biotechnol; 1996 Jan; 44(1-3):75-81. PubMed ID: 8717389
[TBL] [Abstract][Full Text] [Related]
19. [Spread of an intramuscularly administered live gE-negative BHV1 marker vaccine in 2 cattle farms].
van der Poel WH; Hage JJ
Tijdschr Diergeneeskd; 1998 Feb; 123(4):109-11. PubMed ID: 9537086
[TBL] [Abstract][Full Text] [Related]
20. Detection of bovine herpesvirus 1 (BHV-1) genomic sequences in bovine semen inoculated with BHV-1 by polymerase chain reaction.
Kataria RS; Tiwari AK; Gupta PK; Mehrotra ML; Rai A; Bandyopadhyay SK
Acta Virol; 1997 Dec; 41(6):311-5. PubMed ID: 9607088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
